Independent risk factors-based referral tool may help identify PsA in psoriasisMay 17, 2023Psoriatic Arthritis
Low extent and incidence of radiographic spinal damage in PsA vs spondyloarthritisMay 17, 2023Psoriatic Arthritis
Interleukin-17A inhibitor secukinumab safe and effective in oligoarticular PsAMay 17, 2023Psoriatic Arthritis
Pretreatment systemic inflammatory markers may guide therapeutic approach in PsAMay 17, 2023Psoriatic Arthritis
Concomitant methotrexate has no effect on ustekinumab immunogenicity in PsAMay 17, 2023Psoriatic Arthritis
Entheseal fibrocartilage abnormalities: A potential imaging biomarker of PsAMay 17, 2023Psoriatic Arthritis
Upadacitinib safe and effective in PsA patients with axial involvementMay 17, 2023Psoriatic Arthritis
Sonographic enthesitis associated with sonographic synovitis and tenosynovitis in PsAMay 17, 2023Psoriatic Arthritis
Secukinumab improves treatment outcomes and inhibits structural damage in PsAMay 17, 2023Psoriatic Arthritis
Study identifies risk factors associated with PsA occurrence in patients with psoriasisApril 18, 2023Psoriatic Arthritis
Patients with PsA have lower vitamin D levels than general population, says meta-analysisApril 18, 2023Psoriatic Arthritis
